{"url_path":"/sec/oric/8-k/2026-06-22/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1796280/0001193125-26-277511-index.html","accession_number":"0001193125-26-277511","cik":"0001796280","ticker":"ORIC","issuer_name":"Oric Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1796280/0001193125-26-277511-index.html","primary_entity_key":"0001796280","primary_entity_name":"Oric Pharmaceuticals, Inc."},"word_count":483,"has_tables":true,"body_markdown":"Item 5.07. Submission of Matters to a Vote of Security Holders.\n\nOn June 18, 2026, the Company held its annual meeting of stockholders (the “Annual Meeting”). Of the 103,517,562 shares of common stock outstanding as of April 20, 2026, the record date for the meeting, 94,571,281 shares of common stock were represented at the meeting via live webcast or by proxy, constituting 91.36% of the outstanding common stock entitled to vote. The matters voted upon at the meeting and the vote with respect to each such matter are set forth below:\n\nProposal 1 - Election of Directors\n\nThe Company’s stockholders elected each of the following nominees to serve as a Class III director, to hold office until the Company’s 2029 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier death, resignation or removal. The tabulation of votes on this matter was as follows:\n\n \n\nNominees\n\n  \nFor\n \n  \nWithheld\n \n  \nBroker Non-Votes\n \n\nJacob M. Chacko, M.D.\n\n  \n \n89,298,150\n \n  \n \n408,106\n \n  \n \n4,865,025\n \n\nMardi C. Dier\n\n  \n \n82,007,899\n \n  \n \n7,698,357\n \n  \n \n4,865,025\n \n\nProposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm\n\nThe Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The tabulation of votes on this matter was as follows:\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n94,536,096\n \n34,641\n \n544\n \n0\n\n \n\nProposal 3 - Approval of the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as Amended and Restated\n\nThe Company’s stockholders approved the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated. The tabulation of votes on this matter was as follows:\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n61,228,918\n \n27,264,875\n \n1,212,463\n \n4,865,025\n\nProposal 4 - Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers\n\nThe Company’s stockholders approved, on an advisory (non-binding) basis, executive compensation. The tabulation of votes on this matter was as follows:\n\n \n\nFor\n\n \n\nAgainst\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n88,453,809\n \n1,250,074\n \n2,373\n \n4,865,025\n\nProposal 5 - Advisory Vote on the Frequency of Future Stockholder Advisory Votes on the Compensation of the Company’s Named Executive Officers\n\nThe Company’s stockholders approved, on an advisory (non-binding) basis, for the frequency of future stockholder advisory votes regarding executive compensation to be held every one year. In accordance with the recommendation of the Company’s board of directors and the voting results of the Company’s stockholders on this non-binding, advisory vote, the Company will hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers on an annual basis. The next non-binding, advisory vote on the frequency of future stockholder advisory votes on the compensation of the Company’s named execute officers will take place no later than the Company’s annual meeting of stockholders in 2032. The tabulation of votes on this matter was as follows:\n\n \n\nFor One Year\n\n \n\nFor Two Years\n\n \n\nFor Three Years\n\n \n\nAbstain\n\n \n\nBroker Non-Votes\n\n89,392,979\n \n6,986\n \n294,916\n \n11,375\n \n4,865,025"}